Open | - |
Close | - |
Volume / Avg. | 0 / 5.374M |
Day Range | - - - |
52 Wk Range | 0.113 - 1.360 |
Market Cap | $5.861M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.91% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
Other companies in Avenue Therapeutics’s space includes: Cingulate (NASDAQ:CING), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by Maxim Group on Monday, December 11, 2023. The analyst firm set a price target for 0.75 expecting ATXI to rise to within 12 months (a possible 377.40% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $0.1571 last updated March 18, 2024 at 7:35 PM EDT.
There are no upcoming dividends for Avenue Therapeutics.
Avenue Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Avenue Therapeutics.
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.